Biochemistry and regulation of pre-mRNA splicing

Current Opinion in Cell Biology

Volumn 8, Issue 3, 1996, Pages 331-339

  Adams, Melissa D ^a   Rudner, David Z ^a   Rio, Donald C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RNA BINDING PROTEIN; RNA PRECURSOR; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ALTERNATIVE RNA SPLICING; COMPLEX FORMATION; ENZYME MECHANISM; EXON; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; RNA SEQUENCE; RNA SPLICING; SPLICEOSOME;

EID: 0029890441     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80006-8     Document Type: Article

References (86)

1. Horowitz DS, Krainer AR: Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet 1994, 10:100-106.
2. Moore MJ, Query CC, Sharp PA: Splicing of precursors to mRNA by the spliceosome. In The RNA World. Edited by Gesteland RF, Atkins JF. Plainview, New York: Cold Spring Harbor Laboratory Press; 1993:303-358.
3. Fu X-D: The superfamily of arginine/serine-rich splicing factors. RNA 1995, 1:663-680.
4. Black DL: Finding splice sites within a wilderness of RNA. RNA 1995, 1:763-771.
5. Berget SM: Exon recognition in vertebrate splicing. J Biol Chem 1995, 270:2411-2414.
6. Reed R: Initial splice-site recognition and pairing during pre-mRNA splicing. Curr Opin Genet Dev 1996, 6:215-220.
7. Madhani HD, Guthrie C: Dynamic RNA-RNA interactions in the spliceosome Annu Rev Genet 1994, 38:1-26.
8. Umen JG, Guthrie C: The second catalytic step of pre-mRNA splicing. RNA 1995, 1:869-885.
9. Staknis D, Reed R: SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex Mol Cell Biol 1994, 14:7670-7682. Purification and characterization of the pre-spliceosomal early (E) complex indicates that SR proteins bind to the pre-mRNA and stimulate E-complex formation. SR proteins are also found in purified complexes that are formed on splicing enhancer elements.
10. Kohtz JD, Jamison SF, Will CL, Zuo P, Luhrmann R, Garcia-Blanco MA, Manley JL: Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 1994, 368:119-124. Direct demonstration that SR proteins can promote a stable interaction between U1 snRNP and 5′ splice sites.
11. Jamison SF, Pasman Z, Wang J, Will C, Luhrmann R, Manley JL, Garcia-Blanco MA: U1 snRNP-ASF/SF2 interaction and 5′ splice site recognition: characterization of required elements. Nucleic Acids Res 1995, 23:3260-3267.
12. Eperon IC, Ireland DC, Smith RA, Mayeda A, Krainer AR: Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J 1993, 12:3607-3617.
13. Zuo P, Manley JL: The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5′ splice sites. Proc Natl Acad Sci USA 1994, 91:3363-3367.
14. Zahler AM, Roth MB: Distinct functions of SR proteins in recruitment of U1 small nuclear ribonucleoprotein to alternative 5′ splice sites. Proc Natl Acad Sci USA 1995, 92:2642-2646.
15. Wang J, Manley JL: Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1995, 1:335-346.
16. Caceres JF, Stamm S, Helfman DM, Krainer AR: Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994, 265:1706-1709.
17. Lavigueur A, La Branche H, Kornblihtt AR, Chabot B: A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev 1993, 7:2405-2417.
18. Sun Q, Mayeda A, Hampson RK, Krainer AR, Rottman FM: General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev 1993, 7:2598-2608.
19. Dirksen WP, Hampson RK, Sun Q, Rottman FM: A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J Biol Chem 1994, 269:6431-6436.
20. Huh GS, Hynes RO: Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element Genes Dev 1994, 8:1561-1574.
21. Ramchatesingh J, Zahler AM, Neugebauer KM, Roth MB, Cooper TA: A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol 1995, 15:4898-4907.
22. Tian M, Maniatis T: Positive control of pre-mRNA splicing in vitro. Science 1992, 256:237-240.
23. Humphrey MB, Bryan J, Cooper TA, Berget SM: A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol Cell Biol 1995, 15:3979-3988.
24. Watakabe A, Tanaka K, Shimura Y: The role of exon sequences in splice site selection. Genes Dev 1993, 7:407-418.
25. Tanaka K, Watakabe A, Shimura Y: Polypurine sequences within a downstream exon function as a splicing enhancer. Mol Cell Biol 1994, 14:1347-1354.
26. Wang Z, Hoffmann HM, Grabowski PJ: Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1995, 1:21-35. This study demonstrates directly that a splicing enhancer can facilitate 3′ splice-site selection by promoting U2AF binding to the polypyrimidine tract. SR proteins are implicated in this facilitation.
27. Tacke R, Manley JL: The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J 1995, 14:3540-3551.
28. Wu JY, Maniatis T: Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 1993, 75:1061-1070.
29. Chiara MD, Reed R: A two-step mechanism for 5′ and 3′ splice-site pairing. Nature 1995, 375:510-513. This study demonstrates that complexes formed on two separate RNA molecules can functionally interact and undergo trans-splicing in vitro.
30. Bruzik JP, Maniatis T: Enhancer-dependent interaction between 5′ and 3′ splice sites in trans. Proc Natl Acad Sci USA 1995, 92:7056-7059.
31. Ghetti A, Abelson JN: In vitro trans-splicing in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1995, 92:11461-11464.
32. Konforti BB, Konarska MM: A short 5′ splice site RNA oligo can participate in both steps of splicing in mammalian extracts. RNA 1995, 1:815-827.
33. •], shows that SR proteins can bypass the requirement for U1 snRNP in in vitro splicing reactions, by facilitating assembly of functional complexes at the 3′ splice site. U6 snRNA is shown to be involved in specifying the 5′ splice site in the absence of U1 snRNP.
34. •].
35. •].
36. •].
37. Roscigno RF, Garcia-Blanco MA: SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome. RNA 1995, 1:692-706. This work provides the first evidence that SR proteins are involved at a later step than E-complex formation in spliceosome assembly.
38. Blencowe BJ, Nickerson JA, Issner R, Penman S, Sharp PA: Association of nuclear matrix antigens with exon-containing splicing complexes. J Cell Biol 1994, 127:593-607.
39. Blencowe BJ, Issner R, Kim J, McCaw P, Sharp PA: New proteins related to the Ser-Arg family of splicing factors. RNA 1995, 1:852-865.
40. Tian M, Maniatis T: A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell 1993, 74:105-114.
41. Lynch KW, Maniatis T: Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev 1995, 9:284-293.
42. Tian M, Maniatis T: A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev 1994, 8:1703-1712.
43. Chain AC, Zollman S, Tseng JC, Laski FA: Identification of a cis-acting sequence required for germ line-specific splicing of the P element ORF2-ORF3 intron. Mol Cell Biol 1991, 11:1538-1546.
44. Siebel CW, Rio DC: Regulated splicing of the Drosophila P transposable element third intron in vitro: somatic repression. Science 1990, 248:1200-1208.
45. Siebel CW, Fresco LD, Rio DC: The mechanism of somatic inhibition of Drosophila P-element pre-mRNA splicing: multiprotein complexes at an exon pseudo-5′ splice site control U1 snRNP binding. Genes Dev 1992, 6:1386-1401.
46. Siebel CW, Kanaar R, Rio DC: Regulation of tissue-specific P-element pre-mRNA splicing requires the RNA-binding protein PSI. Genes Dev 1994, 8:1713-1725.
47. Siebel CW, Admon A, Rio DC: Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. Genes Dev 1995, 9:269-283.
48. Black DL: Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro. Cell 1992, 69:795-807.
49. Min H, Chan RC, Black DL: The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event Genes Dev 1995, 9:2659-2671.
50. Baker BS: Sex in flies: the splice of life. Nature 1989, 340:521-524.
51. Horabin JI, Schedl P: Regulated splicing of the Drosophila sex-lethal male exon involves a blockage mechanism. Mol Cell Biol 1993, 13:1408-1414.
52. Flickinger TW, Salz HK: The Drosophila sex determination gene snf encodes a nuclear protein with sequence and functional similarity to the mammalian U1A snRNP protein. Genes Dev 1994, 8:914-925.
53. Hitfiker A, Amrein H, Dübendorger A, Schneitet R, Nöthiger R: The gene virilizer is required for female-specific splicing controlled by Sxl, the master gene for sexual development in Drosophila. Development 1995, 121:4017-4026.
54. Gorman M, Baker BS: How flies make one equal two: dosage compensation in Drosophila, Trends Genet 1994, 10:376-380.
55. Zhou S, Yang Y, Scott MJ, Pannuti A, Fehr KC, Eisen A, Koonin EV, Fouts DL, Wrightsman R, Manning JE et al.: Male-specific lethal 2, a dosage compensation gene of Drosophila, undergoes sex-specific regulation and encodes a protein with a RING finger and a metallothionein-like cysteine cluster. EMBO J 1995, 14:2884-2895.
56. Keltey RL, Solovyeva I, Lyman LM, Richman R, Sotovyev V, Kuroda MI: Expression of msl-2 causes assembly of dosage compensation regulators on the X chromosomes and female lethality in Drosophila. Cell 1995, 81:867-877.
57. Bashaw GJ, Baker BS: The msl-2 dosage compensation gene of Drosophila encodes a putative DNA-binding protein whose expression is sex specifically regulated by Sex-lethal. Development 1995, 121:3245-3258.
58. Ring HZ, Lis JT; The SR protein B52/SRp55 is essential for Drosophila development Mol Cell Biol 1994, 14:7499-7506. A null allele of the Drosophila SR protein SRp55/B52 is shown to be essential for viability; the existence of a splicing defect in the dying homozygous mutants is not detected.
59. Kraus ME, Lis JT: The concentration of B52, an essential splicing factor and regulator of splice site choice in vitro, Is critical for Drosophila development. Mol Cell Biol 1994, 14:5360-5370.
60. Kanaar R, Roche SE, Beall EL, Green MR, Rio DC: The conserved pre-mRNA splicing factor U2AF from Drosophila: requirement for viability. Science 1993, 262:569-573.
61. Liao XC, Tang J, Rosbash M: An enhancer screen identifies a gene that encodes the yeast U1 snRNP A protein: implications for snRNP protein function in pre-mRNA splicing. Genes Dev 1993, 7:419-428.
62. Shen J, Zu K, Cass CL, Beyer AL, Hirsh J: Exon skipping by overexpression of a Drosophila heterogeneous nuclear ribonucleoprotein in vivo. Proc Natl Acad Sci USA 1995, 92:1822-1825.
63. Amrein H, Hedley ML, Maniatis T: The role of specific protein-RNA and protein-protein interactions in positive and negative control of pre-mRNA splicing by Transformer 2. Cell 1994, 76:735-746.
64. Valcarcel J, Singh R, Zamore PD, Green MR: The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature 1993, 362:171-175.
65. Lin CH, Patton JG: Regulation of alternative 3′ splice site selection by constitutive splicing factors. RNA 1995, 1:234-245.
66. Singh R, Valcarcel J, Green MR: Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 1995, 268:1173-1176. Iterative genetic selections demonstrate that all pyrimidine-tract-binding proteins are not equal; they have similar but distinct sequence preferences.
67. Sakashita E, Sakamoto H: Characterization of RNA binding specificity of the Drosophila sex-lethal protein by in vitro ligand selection. Nucleic Acids Res 1994, 22:4082-4086.
68. Ghetti A, Pinol-Roma S, Michael WM, Morandi C, Dreyfuss G: hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res 1992, 20:3871-3678.
69. Samuels ME, Bopp D, Colvin RA, Roscigno RF, Garcia-Blanco MA, Schedl P: RNA binding by Sxl proteins in vitro and in vivo. Mol Cell Biol 1994, 14:4975-4990.
70. Kanaar R, Lee AL, Rudner DZ, Wemmer DE, Rio DC: Interaction of the sex-lethal RNA binding domains with RNA. EMBO J 1995, 14:4530-4539.
71. Yean SL, Lin RJ; U4 small nuclear RNA dissociates from a yeast spliceosome and does not participate In the subsequent splicing reaction. Mol Cell Biol 1991, 11:5571-5577.
72. Query CC, Moore MJ, Sharp PA: Branch nucleophile selection In pre-mRNA splicing; evidence for the bulged duplex model. Genes Dev 1994, 8:587-597. Site-specific modifications using deoxynucleotides and arabinosyl nucleotides within the branch sequence are used to directly test the bulged duplex model of splicing. U2 snRNA interaction with the branch site is shown to identify and activate the first step nucleophile and to persist at the time of the first transesterification reaction.
73. Sun JS, Manley JL: A novel U2-U6 snRNA structure is necessary for mammalian mRNA splicing. Genes Dev 1995, 9:843-854. Using a genetic suppression assay, in mammalian tissue culture, a novel intermolecular helix (heitx III) between U2 and U6 is identified. Evidence that this helix helps to juxtapose the 5′ splice site and the branch site is provided by suppression of a branch-site mutation by a network of compensatory changes in the 5′ splice site and in the U2 and U6 snRNAs.
74. Madhani HO, Guthrie C: Randomization-selection analysis of snRNAs in vivo evidence for a tertiary interaction in the spliceosome. Genes Dev 1994, 8:1071-1086. Randomization of U2 and U6 snRNAs and selection in yeast for covariants is used to functionally dissect critical interactions between U2 and U6.
75. Sontheimer El, Steitz JA: The U5 and U6 small nuclear RNAs as active site components of the spliceosome. Science 1993, 262:1989-1996.
76. Wolff T, Menssen R, Hammel J, Bindereif A: Splicing function of mammalian U6 small nuclear RNA: conserved positions In central domain and helix I are essential during the first and second step of pre-mRNA splicing. Proc Natl Acad Sci USA 1994, 91:903-907.
77. Gozani R, Feld R, Reed R: Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site Is required for assembly of spliceosomal complex A. Genes Dev 1996, 10:233-243.
78. Gaur RK, Valcarcel J, Green MR: Sequential recognition of the pre-mRNA branch point by U2AF65 and a novel spliceosome-associated 28-kDa protein. RNA 1995, 1:407-417.
79. MacMillan AM, Query CC, Allerson CR, Chen S, Verdine GL, Sharp PA: Dynamic association of proteins with the pre-mRNA branch region. Genes Dev 1994, 8:3008-3020. Site-specific modification using the photoreagent benzophenone is used to identify three sets of proteins that associate with the branch region during the course of spliceosome assembly and catalysis.
80. Teigelkamp S, Newman AJ, Beggs JD: Extensive interactions of PRP8 protein with the 5′ and 3′ splice sites during splicing suggest a role in stabilization of exon alignment by US snRNA. EMBO J 1995, 14:2602-2612. Extensive mapping of PRP8 binding to pre-mRNA (using either UV to cross-link bases or site specifically modified bases) demonstrates an interaction of PRP8 with both the exon at the 5′ splice site and the pyrimidine tract at the 3′ splice site.
81. Umen JG, Guthrie C: A novel role for a U5 snRNP protein in 3′ splice site selection. Genes Dev 1995, 9:855-868. Isolation of a mutation in PRP8 that eliminates undine-containing 3′ splice-site preference in yeast, and implicates the integral U5 snRNP protein in the second catalytic step and 3′ splice-site recognition.
82. Wyatt JR, Sontheimer EJ, Steitz JA: Site-specific cross-linking of mammalian US snRNP to the 5′ splice site before the first step of pre-mRNA splicing. Genes Dev 1992, 6:2542-2553.
83. Lindsey LA, Crow AJ, Garcia-Blanco MA: A mammalian activity required for the second step of pre-messenger RNA splicing. J Biol Chem 1995, 270:13415-13421.
84. Jones MH, Frank DN, Guthrie C: Characterization and functional ordering of Slu7p and Prp17p during the second step of pre-mRNA splicing in yeast. Proc Natl Acad Sci USA 1995, 92:9687-9691.
85. Horowitz OS, Abelson J: Stages in the second reaction of pre-mRNA splicing: the final step is ATP independent Genes Dev 1993, 7:320-329.
86. Ansari A, Schwer B: SLU7 and a novel activity, SSF1, act during the PRP16-dependent step of yeast pre-mRNA splicing, EMBO J 1995, 14:4001-4009.